About Parabolica Therapeutics
Parabolica Therapeutics is a private company based in Dallas, Texas, incorporated in 2025 in Delaware. It has reported $50,000 raised in one offering on Form D since April 2026. Its chief executive is Andrew Wang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Apr 30, 2026 | $50,000of $250K target | 2 | $25,000 | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Parabolica Therapeutics's Form D filed Apr 30, 2026.
BB
Brian Brille
Director
AW
Andrew Wang
Chief Executive Officer and director
NC
Narendra Chokshi
Executive officer and director